Quest Diagnostics admitted in early January that thousands of its vitamin D tests conducted over the last two years were incorrect. In a letter to doctors, Quest said the test has now been fixed and offered free retests. Vitamin D deficiency has been linked to several diseases, and test volumes have doubled on an annual […]
Pharmaceuticals and Biotech IMS Health forecasts worldwide pharmaceutical sales to increase 4.5%–5.5% this year, on par with 2008, to more than $820 billion (see IBO 10/31/08). The substantial cash holdings of major pharmaceutical companies could increase M&A activities. The target of these acquisitions are expected to be smaller biotech firms that are unable to access […]
IBO has been publishing its annual instrument industry forecast issue since 1993, but never have we been confronted with the level of uncertainty that hangs over the industry at this time. Normally, economic ups and downs in various regions of the world do not have that much of an impact on the industry because of […]
Growth in 2008 for the separations market was nearly two percentage points lower than the original forecast estimates (see IBO 1/15/08) due, in part, to the weakened third and fourth quarters marked by the global financial crisis. In 2008, the separations market accounted for $6.6 billion in revenues and grew 6.6% over 2007. For 2009, […]
Financial Crisis As with firms worldwide, analytical and life science instrument companies found themselves at the mercy of the credit crisis, failing stock markets and lower industrial demand at year-end. Some of the strongest markets for instrumentation in recent years—the petrochemical, metals and chemical industries—abruptly slowed operations in late 2008 and announced cost cuts for […]
A new survey by KPMG and the Semiconductor Industry Association finds that semiconductor companies do not expect an industry recovery any time soon. The November survey interviewed 85 senior executives at device, foundry and fabless companies. Fifty-two percent of the executives expect revenues to decrease and 69% expect profitability to decline over the next year […]
This year will be a period most investors would soon rather forget, as virtually all international stock markets suffered significant losses due to the current global economic crisis. For the year, the Dow Jones World Index fell approximately 43%, despite international efforts to lower interest rates and increase spending through massive bailout plans. The credit […]
At the beginning of the month, the California Institute for Regenerative Medicine (CIRM) announced its first Tools and Technologies Awards. Established in 2004 as the result of the passage of a California ballot proposition, the nonprofit CIRM is charged with distributing $3 billion in loans and grants for stem cell research to public and private […]
A meeting of the FDA’s Oncologic Drugs Advisory Committee earlier this month discussed the use of retrospective biomarker data in making regulatory decisions. Amgen and ImClone are seeking approval to include such data on drug labels. Amgen’s Vectibix and ImClone’s Erbitux are monoclonal antibodies used to treat colon cancer. Amgen is also seeking approval of […]
According to Battelle and R&D Magazine, R&D spending worldwide will increase by approximately 3.2% next year to $1,140 billion, excluding inflation. US R&D spending is estimated to increase 1.75% to $383.5 billion, excluding inflation. Including the effects of inflation, US R&D spending is forecasted to decline 1.6%, as federal government funding falls 1.9% and industrial […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
